Shilpa Medicare Limited
Process Development

Process Development

Specialized infrastructure & expert teams for safe, compliant development & manufacture of high-potency APIs, including for oncology.

Overview

We provide end-to-end HPAPI services from early route identification through commercial-scale cGMP supply. Our facilities include multiple dedicated HPAPI suites (OEL / OEB compliance), isolator technology, enriched analytical lab support, and a robust payload/linker library. We support both oncology & non-oncology high potency compounds.

2. Process Development

Purpose & What We Do

  • Optimize the selected synthetic route for performance, yield, impurity profile, scalability, and containment
  • Define Critical Process Parameters (CPPs), Critical Quality Attributes (CQAs), and establish control strategies

Key Activities

  • Lab / pilot scale optimization: reaction conditions (temp, time, concentration), solvent selection, reagent equivalents, catalysts, purification procedures
  • Developing purification / isolation strategies tailored for HP compounds (e.g. minimizing cross-contamination, ensuring deactivation of residual HP residues)
  • Mechanistic / kinetic studies, determining reaction order, rate-limiting steps
  • Analytical method development and validation (for potency, purity, residuals)

Deliverables

  • Fully optimized synthetic process with defined CPP ranges
  • Analytical methods for release AND in-process testing
  • Pilot batches for scale-down / scale-up studies
  • Process safety plan (including handling, containment, waste management)